Stay updated on Phase II Pembrolizumab Plus GVD Clinical Trial
Sign up to get notified when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.

Latest updates to the Phase II Pembrolizumab Plus GVD Clinical Trial page
- Check7 days agoChange DetectedEligibility criteria now require lab values from before Cycle 1 of Pembrolizumab-GVD. Renal function is assessed by eGFR (≥60 mL/min), replacing prior CrCl/GFR language.SummaryDifference0.3%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.3.2 added and v3.2.0 removed. This update does not affect study details or eligibility criteria.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the government funding status notice/banner from the page. The study details, including interventions, criteria, and contacts, remain unchanged.SummaryDifference0.3%

- Check42 days agoChange DetectedThe page shows minor visual/layout updates and an updated last-updated timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedCore content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.SummaryDifference2%

- Check78 days agoChange DetectedUpdates to page metadata: version bumped to v3.1.0 with new date ranges and contact numbers added, while older version references and past dates are deleted.SummaryDifference0.6%

Stay in the know with updates to Phase II Pembrolizumab Plus GVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.